What nurse practitioners should know about direct-to-consumer advertising of prescription medications
- PMID: 12929250
- DOI: 10.1111/j.1745-7599.2003.tb01312.x
What nurse practitioners should know about direct-to-consumer advertising of prescription medications
Abstract
Purpose: To describe the marketing strategies of direct-to-consumer (DTC) advertising and the risks, benefits, and potential influence on the prescribing practices of nurse practitioners (NPs).
Data sources: Journal articles, media sources, and clinical experience.
Conclusions: The effect of DTC advertising of prescription medications on NPs has not been well studied. Although there are studies that examine the effects of DTC advertising on physician prescribing as well as the effects of this practice on the consumer, opinions on the benefits of DTC advertising are varied.
Implications for practice: NPs need to recognize the potential influence of DTC advertising and to be prepared to guide patients toward appropriate medication choices by participating in a partnership with patients. Health care providers, including NPs, need to work with the pharmaceutical industry to encourage accountability of DTC advertising, thus improving dissemination of correct information and promoting positive outcomes for health consumers and patients.
Similar articles
-
The attitudes and beliefs of oncology nurse practitioners regarding direct-to-consumer advertising of prescription medications.Oncol Nurs Forum. 2004 Jul 13;31(4):777-83. doi: 10.1188/04.ONF.777-783. Print 2004 Jul. Oncol Nurs Forum. 2004. PMID: 15252431
-
Direct-to-consumer advertising of prescription medications: implications for patients with cancer.Oncol Nurs Forum. 2002 Apr;29(3):505-13. doi: 10.1188/02.ONF.505-513. Oncol Nurs Forum. 2002. PMID: 11979283
-
Direct-to-consumer prescription drug advertising: trends, impact, and implications.Health Aff (Millwood). 2000 Mar-Apr;19(2):110-28. doi: 10.1377/hlthaff.19.2.110. Health Aff (Millwood). 2000. PMID: 10718026 Review.
-
A 3-stage model for assessing the probable economic effects of direct-to-consumer advertising of pharmaceuticals.Clin Ther. 2003 Jan;25(1):309-29. doi: 10.1016/s0149-2918(03)90043-9. Clin Ther. 2003. PMID: 12637129
-
Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers.Pharmacoeconomics. 2001;19(2):109-19. doi: 10.2165/00019053-200119020-00001. Pharmacoeconomics. 2001. PMID: 11284378 Review.
Cited by
-
Educating health professionals about drug and device promotion: advocates' recommendations.PLoS Med. 2006 Nov;3(11):e451. doi: 10.1371/journal.pmed.0030451. PLoS Med. 2006. PMID: 17090212 Free PMC article.
-
Drug information resources used by nurse practitioners and collaborating physicians at the point of care in Nova Scotia, Canada: a survey and review of the literature.BMC Nurs. 2006 Jul 6;5:5. doi: 10.1186/1472-6955-5-5. BMC Nurs. 2006. PMID: 16822323 Free PMC article.
-
Soft targets: nurses and the pharmaceutical industry.PLoS Med. 2008 Feb;5(2):e5. doi: 10.1371/journal.pmed.0050005. PLoS Med. 2008. PMID: 18254652 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical